Person who experienced the adverse event (patient)
| Event ID | CASEID | CASEVERSION | I F COD | EVENT DT | MFR DT | INIT FDA DT | FDA DT | REPT COD | AUTH NUM | MFR NUM | MFR SNDR | LIT REF | AGE | AGE COD | AGE GRP | GNDR COD | E SUB | WT | WT COD | REPT DT | TO MFR | OCCP COD | REPORTER COUNTRY | OCCR COUNTRY |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| 126096261 | 12609626 | 1 | I | 20160725 | 20160801 | 20160801 | EXP | US-HORIZON-PRE-0233-2016 | HORIZON | WILBERGER AC, PRAYSON RA. INTRACRANIAL INVOLVEMENT OF POSTTRANSPLANT LYMPHOPROLIFERATIVE DISORDER MULTIPLE MYELOMA. J CLIN NEUROSCI. 2015;22(11):1850-1. | 61.00 | YR | A | M | Y | 0.00000 | 20160729 | MD | US | US |
Drug(s) used by person
| Event ID | CASEID | DRUG SEQ | ROLE COD | DRUGNAME | PROD AI | VAL VBM | ROUTE | DOSE VBM | CUM DOSE CHR | CUM DOSE UNIT | DECHAL | RECHAL | LOT NUM | EXP DT | NDA NUM | DOSE AMT | DOSE UNIT | DOSE FORM | DOSE FREQ |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| 126096261 | 12609626 | 1 | PS | PREDNISONE. | PREDNISONE | 1 | U | 202020 | |||||||||||
| 126096261 | 12609626 | 2 | SS | TACROLIMUS. | TACROLIMUS | 1 | U | 0 | |||||||||||
| 126096261 | 12609626 | 3 | SS | MYCOPHENOLATE MOFETIL. | MYCOPHENOLATE MOFETIL | 1 | U | 0 |
Indications of drugs used
| Event ID | CASEID | INDI DRUG SEQ | INDI PT |
|---|---|---|---|
| 126096261 | 12609626 | 1 | Immunosuppression |
| 126096261 | 12609626 | 2 | Immunosuppression |
| 126096261 | 12609626 | 3 | Immunosuppression |
Outcome of event
| Event ID | CASEID | OUTC COD |
|---|---|---|
| 126096261 | 12609626 | OT |
Reactions reported
| Event ID | CASEID | DRUG REC ACT | PT |
|---|---|---|---|
| 126096261 | 12609626 | Post transplant lymphoproliferative disorder |
Reporting Sources (this data is often not reported and may therefore be missing here)
| no results found |
Therapies reported
| no results found |